Close

Trending

PARP rivals close in on AZ and Merck’s market leading Lynparza

Unlocking the potential of connected commercialisation solutions

Considerations for Mobile Health Technology Developers: Part 2

Novo Nordisk achieve headline results with icodec insulin

Roche gets FDA approval for HER2 breast cancer diagnostic

UK & Europe

UK & Europe

Digital/ News/ News/ UK & Europe

ResMed joins Google to research sleep apnoea therapies

Richard Staines digital health, ResMed, sleep apnoea, Verily 0 Comment

ResMed combines apnoea expertise with Verily’s AI capabilities

X

ResMed joins Google to research sleep apnoea therapies

https://pharmaphorum.com/news/resmed-joins-google-to-research-sleep-apnoea-therapies/

Brexit

Brexit/ News/ UK & Europe

UK pharma welcomes May’s Brexit plan

Richard Staines Brexit, European Medicines Agency, regulation 0 Comment

Proposals finally outlined in White Paper

X

UK pharma welcomes May’s Brexit plan

https://pharmaphorum.com/news/uk-pharma-welcomes-mays-brexit-plan/

Brexit Health Alliance warns on infection threat

News/ R&D/ UK & Europe

UK government kick-starts AMR research with £10m grant

Richard Staines antimicrobial resistance, infectious diseases, R&D 0 Comment

Tackling AMR is long-term government goal

X

UK government kick-starts AMR research with £10m grant

https://pharmaphorum.com/news/uk-government-kick-starts-amr-research-10m-grant/

matt_hancock_capture

Brexit/ News/ UK & Europe

Matt Hancock appointed health secretary in Brexit reshuffle

Joy Persaud Brexit, digital NHS, NHS 0 Comment

Hancock takes over from longest-serving health sec Jeremy Hunt

X

Matt Hancock appointed health secretary in Brexit reshuffle

https://pharmaphorum.com/news/matt-hancock-appointed-health-secretary-in-brexit-reshuffle/

NICE1

News/ UK & Europe

NICE restricts use of antibiotics in draft COPD guidance

Richard Staines COPD, NICE, respiratory 0 Comment

NICE has published draft guidance restricting use of antibiotics in patients with chronic obstructive pulmonary disease (COPD), as

X

NICE restricts use of antibiotics in draft COPD guidance

https://pharmaphorum.com/news/nice-restricts-use-of-antibiotics-in-draft-copd-guidance/

NHS

News/ News/ Patients/ UK & Europe

Pharma takes leading role in NHS 70th anniversary celebrations

Joy Persaud AstraZeneca, NHS, NHS 70 years, Novartis, Pfizer 0 Comment

The pharmaceutical industry celebrated the 70th anniversary of the NHS by recognising the myriad contributions that the sector

X

Pharma takes leading role in NHS 70th anniversary celebrations

https://pharmaphorum.com/news/pharma-takes-leading-role-in-nhs-70th-anniversary-celebrations/

Roche Rituxan approval

Market Access/ News/ News/ News/ Oncology/ Roche/ Top stories/ UK & Europe

NICE okays Roche rare lung cancer drug after price cut

Richard Staines cancer, lung cancer, Pfizer, Roche 0 Comment

Alecensa has aced Pfizer’s rival in head-to-head trial

X

NICE okays Roche rare lung cancer drug after price cut

https://pharmaphorum.com/market-access-2/nice-okays-roche-rare-lung-cancer-drug-after-price-cut/

European Medicines Agency London

News/ Top stories/ UK & Europe

EU freezing UK out of drug safety scheme after Brexit

Richard Staines Brexit, regulation, safety 0 Comment

The European Medicines Agency is planning to freeze the UK out of its drug safety monitoring system after

X

EU freezing UK out of drug safety scheme after Brexit

https://pharmaphorum.com/news/uk-frozen-eudravigilance/

NICE1

Market Access/ News/ News/ Roche/ UK & Europe

NICE okays NHS funding for MS and eczema drugs

Richard Staines atopic dermatitis, multiple sclerosis, NICE, Roche, Sanofi 0 Comment

The UK’s NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in

X

NICE okays NHS funding for MS and eczema drugs

https://pharmaphorum.com/news/nice-okays-nhs-funding-for-ms-and-eczema-drugs/

«‹ 2 3 4 5 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com